Jeff Geschwind’s innovations combine tumor metabolism analysis with precision Cone Beam CT-guided TACE, transforming liver cancer treatment. His approach improves tumor mapping, targets metabolic weaknesses, and enhances embolization success, setting new benchmarks in interventional oncology. https://www.slideshare.net/slideshow/dr-jeff-geschwind-a-leader-in-interventional-oncology-and-radiology-docx/275010710